We’re proud to share that our CEO and Editor-in-Chief Alvaro Fernandez is participating in a fascinating and timely 2‑day meeting, hosted by The Banbury Center at Cold Spring Harbor Laboratory under the theme The evolving phenomenon of Direct-to-Consumer Neuroscience, to help identify and address key open regulatory/ ethical issues related to the growth of pervasive neurotechnologies and digital brain health platforms offered/ sold directly to consumers.
The event is off-the-record so we won’t be able to blog about it, but here are some resources if interested in learning more about the general context for the event:
- The FDA creates new Digital Health unit to reimagine regulatory paths in the age of scalable, AI-enhanced innovation
- Five reasons the future of brain enhancement is digital, pervasive and (hopefully) bright
- FDA clears first CBT-based digital therapeutic to treat substance abuse disorders
- The Federal Trade Commission vs Lumosity: What does it mean for the brain training market?
- Maker of “neuro” functional drinks settles false advertising complaint
- The Federal Trade Commission challenges brain health claims by Procera AVH dietary supplement
- Who knows more about improving vision, a) the Federal Trade Commission or b) 60+ vision scientists
- Important insights on the growing home use of tDCS brain stimulation: older-than-expected users, positive self-reported results for treatment of depression but negative for self-enhancement, and a couple areas of concern (severe burns, frequency)
- Solving the Brain Fitness Puzzle Is the Key to Self-Empowered Aging
- Presentations during the session How will the Clinicians, Patients and Consumers of the Future ensure appropriate use of brain enhancement methods at the 2017 SharpBrains Virtual Summit: